KG
COLL icon

Kilter Group’s Collegium Pharmaceutical COLL Stock Holding History

Kilter Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6K Buy
652
+330
+102% +$11.3K 0.01% 258
2026
Q1 		$10.6K Buy
+322
New +$13.6K ﹤0.01% 385

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Kilter Group's COLL Position: Q2 2026 in Review

Kilter Group increased its Collegium Pharmaceutical (COLL) stake by 102% in Q2 2026, buying an estimated $11.3K and bringing the position to 652 shares worth $23.6K. The position accounts for 0.01% of the portfolio, ranked #258.

Kilter Group first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Kilter Group held 652 shares of Collegium Pharmaceutical worth $23.6K as of Q2 2026.
  • Kilter Group bought 330 Collegium Pharmaceutical shares in Q2 2026, an estimated $11.3K.
  • Collegium Pharmaceutical made up 0.01% of Kilter Group's portfolio in Q2 2026, its #258 holding.
  • Kilter Group first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.